Advertisement

Brachytherapy pp 301-304 | Cite as

Intraluminal Brachytherapy for Biliary Tract Cancer

  • Naoya Murakami
  • Jun ItamiEmail author
Chapter

Abstract

In this chapter, intraluminal brachytherapy (ILBT) for biliary tract cancer is discussed. Because of its rarity and poor prognosis and generally it is difficult to cover whole tumor with intraluminal brachytherapy, there exists no prospective study showing survival benefit of ILBT for biliary tract cancer. However, large retrospective study showed effectiveness of ILBT in local control for unresectable biliary tract cancer patients. Local control of the disease holds great significance for such patients; therefore, ILBT could be considered when applicable.

Keywords

Biliary tract cancer Intraluminal brachytherapy 

References

  1. 1.
    Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan.Google Scholar
  2. 2.
    Anderson CD, Pinson CW, Berlin J, et al. Diagnosis and treatment of cholangiocarcinoma. Oncologist. 2004;9:43–57.CrossRefPubMedGoogle Scholar
  3. 3.
    Ikeda K, Kuroda C, Uchida H, et al. Intraluminal irradiation with Ir-192 wires for extrahepatic bile duct carcinoma. Nihon Igaku Houshasen Gakkai Zasshi. 1979;39:1356–8.Google Scholar
  4. 4.
    Koster R, Schmidt H, Greuel H, et al. Bestrahlung von malignen Gallengangsverschlüssen in Afterloading-Technik. Strahlentherapie. 1982;158:678–80.PubMedGoogle Scholar
  5. 5.
    Itami J, Saegusa Y, Tsuchiya T, et al. Intrakavitaere high-dose-rate-afterloading-Bestrahlung beim inoperablen malignen Gallengangsverschluss. Strahlenther Onkol. 1986;162:105–10.PubMedGoogle Scholar
  6. 6.
    Montemaggi O, Costamagna G, Dobelbower R, et al. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1995;32:437–43.CrossRefPubMedGoogle Scholar
  7. 7.
    Kamada T, Saitou H, Takamura A, et al. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34:767–74.CrossRefPubMedGoogle Scholar
  8. 8.
    Gonzalez D, Gouma D, Rauws E, et al. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Ann Oncol. 1999;10:215–20.CrossRefGoogle Scholar
  9. 9.
    Yoshioka Y, Ogawa K, Oikawa H, et al. Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: a propensity score matched-pair analysis. Int J Radiation Oncol Biol Phys. 2014;89(4):822e829.CrossRefGoogle Scholar
  10. 10.
    Mattiucci GC, Autorino R, Tringali A, et al. A phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer. Brachytherapy. 2015;14:401–4.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Radiation OncologyNational Cancer Center HospitalTokyoJapan

Personalised recommendations